The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not?
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Cancer Research, Statistics, and Treatment |
| Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=579;epage=580;aulast=Jain |
| _version_ | 1818893076664418304 |
|---|---|
| author | Arpit Jain Srujana Joga Amrith B Patel |
| author_facet | Arpit Jain Srujana Joga Amrith B Patel |
| author_sort | Arpit Jain |
| collection | DOAJ |
| first_indexed | 2024-12-19T18:06:51Z |
| format | Article |
| id | doaj.art-93b2244d568e458282a9006dd861451d |
| institution | Directory Open Access Journal |
| issn | 2590-3233 2590-3225 |
| language | English |
| last_indexed | 2024-12-19T18:06:51Z |
| publishDate | 2021-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Cancer Research, Statistics, and Treatment |
| spelling | doaj.art-93b2244d568e458282a9006dd861451d2022-12-21T20:11:26ZengWolters Kluwer Medknow PublicationsCancer Research, Statistics, and Treatment2590-32332590-32252021-01-014357958010.4103/crst.crst_190_21The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not?Arpit JainSrujana JogaAmrith B Patelhttp://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=579;epage=580;aulast=Jain |
| spellingShingle | Arpit Jain Srujana Joga Amrith B Patel The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? Cancer Research, Statistics, and Treatment |
| title | The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? |
| title_full | The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? |
| title_fullStr | The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? |
| title_full_unstemmed | The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? |
| title_short | The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not? |
| title_sort | cost containment strategy by optimizing the bevacizumab dose for glioblastoma worthy or not |
| url | http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=3;spage=579;epage=580;aulast=Jain |
| work_keys_str_mv | AT arpitjain thecostcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot AT srujanajoga thecostcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot AT amrithbpatel thecostcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot AT arpitjain costcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot AT srujanajoga costcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot AT amrithbpatel costcontainmentstrategybyoptimizingthebevacizumabdoseforglioblastomaworthyornot |